Condition

Hematopoietic and Lymphoid Cell Neoplasm

ClinicalTrials.gov condition label

Clinical trials37

Recruiting7

Common interventions25

Lead sponsors shown11

Clinical trials

37 shown

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersNCT05663502 · 2023-05-10

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi MethodNCT05054413 · 2021-04-15

The Impact of COVID-19 on Pulmonary ProceduresNCT05022446 · 2020-11-11

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and SurvivorsNCT04551378 · 2020-07-13

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyNCT00991094 · 2005-05-27

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyNCT04593277 · 2022-10-23

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06

The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood CancerNCT05023993 · 2022-06-23

ACTIVE_NOT_RECRUITING

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)NCT05250037 · 2022-03-30

ACTIVE_NOT_RECRUITING

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB StudyNCT05135650 · 2022-01-25

Remote Monitoring in Cancer Care: A Platform StudyNCT05018208 · 2021-12-15

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 PandemicNCT05102656 · 2021-06-02

ACTIVE_NOT_RECRUITING

Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerNCT05058339 · 2021-04-27

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesNCT04789668 · 2021-01-15

SARS-CoV-2 Donor-Recipient Immunity TransferNCT04666025 · 2020-09-23

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialNCT04190433 · 2020-09-01

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and TelehealthNCT04630015 · 2020-08-31

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical PneumoniaNCT04565665 · 2020-07-29

ACTIVE_NOT_RECRUITING

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesNCT02962661 · 2020-07-18

Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID StudyNCT04652505 · 2020-07-13

Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 PandemicNCT04500600 · 2020-06-11

ACTIVE_NOT_RECRUITING

Tocilizumab for Patients With Cancer and COVID-19 DiseaseNCT04370834 · 2020-05-28

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical TrialsNCT04650178 · 2020-05-26

ACTIVE_NOT_RECRUITING

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung CancerNCT05106374 · 2018-09-04

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation TherapyNCT03080883 · 2017-07-14

Carvedilol in Preventing Heart Failure in Childhood Cancer SurvivorsNCT02717507 · 2016-04-04

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesNCT02706392 · 2016-03-16

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)NCT04439175 · 2016-02-25

ACTIVE_NOT_RECRUITING

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)NCT04439292 · 2016-01-04

ACTIVE_NOT_RECRUITING

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17

ACTIVE_NOT_RECRUITING

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)NCT04439253 · 2015-08-12

ACTIVE_NOT_RECRUITING

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)NCT04439266 · 2015-08-12

ACTIVE_NOT_RECRUITING

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)NCT04439110 · 2015-08-12

ACTIVE_NOT_RECRUITING

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionNCT01638533 · 2012-08-03

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic CancerNCT00968630 · 2009-12-17

Common interventions

Leading sponsors

M.D. Anderson Cancer Center12 National Cancer Institute (NCI)9 Fred Hutchinson Cancer Center6 City of Hope Medical Center2 Mayo Clinic2 Academic and Community Cancer Research United1 AIDS Malignancy Consortium1 Alliance for Clinical Trials in Oncology1 Children's Oncology Group1 Ohio State University Comprehensive Cancer Center1 University of California, San Francisco1

Trial status mix

ACTIVE_NOT_RECRUITING12

COMPLETED11

RECRUITING7

TERMINATED5

SUSPENDED1

WITHDRAWN1

Phase mix

PHASE213

PHASE17

NA3

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.